WELL HEALTH TECHNOLOGIES CORP. EARLY WARNING NEWS RELEASE
WELL Health Technologies Corp. (WHTCF) has announced its intention to exercise a call option to acquire shares in HEALWELL AI Inc. concurrent with HEALWELL's acquisition of Orion Health Holdings The call option allows WELL to purchase up to 30.8 million Subordinate Voting Shares and 30.8 million Multiple Voting Shares from HEALWELL's founding shareholders at $0.125 and $0.0001 per share respectively.
HEALWELL is set to acquire Orion Health for approximately NZ$175 million, with closing anticipated on April 1, 2025. Following the exercise of the call right and the Orion Health acquisition, WELL is expected to own approximately 37% of the economic interest and 69% of the voting rights in HEALWELL on a partially-diluted basis. WELL was previously approved as a control person of HEALWELL by shareholders and the Toronto Stock Exchange.
WELL Health Technologies Corp. (WHTCF) ha annunciato la sua intenzione di esercitare un'opzione di acquisto per acquisire azioni di HEALWELL AI Inc. in concomitanza con l'acquisizione di Orion Health Holdings da parte di HEALWELL. L'opzione di acquisto consente a WELL di acquistare fino a 30,8 milioni di azioni con diritto di voto subordinato e 30,8 milioni di azioni con diritto di voto multiplo dai soci fondatori di HEALWELL a $0,125 e $0,0001 per azione rispettivamente.
HEALWELL è pronta ad acquisire Orion Health per circa NZ$175 milioni, con chiusura prevista per il 1 aprile 2025. Dopo l'esercizio del diritto di acquisto e l'acquisizione di Orion Health, si prevede che WELL possieda circa il 37% dell'interesse economico e il 69% dei diritti di voto in HEALWELL su base parzialmente diluita. WELL era stata precedentemente approvata come persona di controllo di HEALWELL dagli azionisti e dalla Borsa di Toronto.
WELL Health Technologies Corp. (WHTCF) ha anunciado su intención de ejercer una opción de compra para adquirir acciones de HEALWELL AI Inc. al mismo tiempo que HEALWELL adquiere Orion Health Holdings. La opción de compra permite a WELL adquirir hasta 30,8 millones de acciones con derecho de voto subordinado y 30,8 millones de acciones con derecho de voto múltiple de los accionistas fundadores de HEALWELL a $0,125 y $0,0001 por acción respectivamente.
HEALWELL está a punto de adquirir Orion Health por aproximadamente NZ$175 millones, con cierre anticipado para el 1 de abril de 2025. Tras el ejercicio del derecho de compra y la adquisición de Orion Health, se espera que WELL posea aproximadamente el 37% del interés económico y el 69% de los derechos de voto en HEALWELL en una base parcialmente diluida. WELL había sido previamente aprobada como persona de control de HEALWELL por los accionistas y la Bolsa de Valores de Toronto.
WELL Health Technologies Corp. (WHTCF)는 HEALWELL AI Inc.의 주식을 인수하기 위한 콜 옵션을 행사할 의사를 발표했습니다. 이는 HEALWELL이 Orion Health Holdings를 인수하는 것과 동시에 이루어집니다. 이 콜 옵션은 WELL이 HEALWELL의 창립 주주로부터 각각 $0.125와 $0.0001에 최대 3,080만 주의 보통주 및 3,080만 주의 다중 투표 주식을 구매할 수 있도록 합니다.
HEALWELL은 약 NZ$175 million에 Orion Health를 인수할 예정이며, 거래 종료는 2025년 4월 1일로 예상됩니다. 콜 옵션 행사와 Orion Health 인수 이후, WELL은 HEALWELL에서 경제적 이익의 약 37%와 투표권의 69%를 소유할 것으로 예상됩니다. WELL은 이전에 HEALWELL의 통제자로 주주와 토론토 증권 거래소에 의해 승인받았습니다.
WELL Health Technologies Corp. (WHTCF) a annoncé son intention d'exercer une option d'achat pour acquérir des actions de HEALWELL AI Inc. en même temps que l'acquisition d'Orion Health Holdings par HEALWELL. L'option d'achat permet à WELL d'acheter jusqu'à 30,8 millions d'actions avec droit de vote subordonné et 30,8 millions d'actions avec droit de vote multiple auprès des actionnaires fondateurs de HEALWELL à respectivement 0,125 $ et 0,0001 $ par action.
HEALWELL est sur le point d'acquérir Orion Health pour environ 175 millions NZ$, avec une clôture prévue le 1er avril 2025. Suite à l'exercice du droit d'achat et à l'acquisition d'Orion Health, WELL devrait posséder environ 37% de l'intérêt économique et 69% des droits de vote dans HEALWELL sur une base partiellement diluée. WELL avait auparavant été approuvée en tant que personne de contrôle de HEALWELL par les actionnaires et la Bourse de Toronto.
WELL Health Technologies Corp. (WHTCF) hat seine Absicht angekündigt, eine Kaufoption auszuüben, um Aktien von HEALWELL AI Inc. zu erwerben, während HEALWELL Orion Health Holdings erwirbt. Die Kaufoption erlaubt es WELL, bis zu 30,8 Millionen nachrangige stimmberechtigte Aktien und 30,8 Millionen Mehrfachstimmrechte von den Gründungsaktionären von HEALWELL zu einem Preis von jeweils $0,125 und $0,0001 pro Aktie zu kaufen.
HEALWELL wird Orion Health voraussichtlich für etwa NZ$175 Millionen erwerben, wobei der Abschluss für den 1. April 2025 erwartet wird. Nach Ausübung des Kaufrechts und der Übernahme von Orion Health wird erwartet, dass WELL etwa 37% des wirtschaftlichen Interesses und 69% der Stimmrechte an HEALWELL auf einer teilweise verwässerten Basis besitzen wird. WELL wurde zuvor von den Aktionären und der Toronto Stock Exchange als Kontrollperson von HEALWELL genehmigt.
- Significant voting control acquisition (69% voting rights) in HEALWELL
- Strategic expansion through indirect exposure to Orion Health acquisition
- Favorable share purchase terms at $0.125 per share for substantial stake
- Substantial capital commitment required for share acquisition
- Increased exposure to HEALWELL's business risks and Orion Health integration
Proposed Exercise of Call Right
On October 1, 2023, WELL and the founding shareholders of HEALWELL AI Inc. ("HEALWELL"), Dr. Sven Grail ("Dr. Grail") and Dr. George Christodoulou ("Dr. Christodoulou"), entered into a call option agreement (the "Call Option Agreement"), under which WELL was granted a call option (the "Call Right") to acquire up to 30.8 million Subordinate Voting Shares of HEALWELL (each, a "HEALWELL Share") and 30.8 million Multiple Voting Shares of HEALWELL (each, a "MVS") from Dr. Grail and Dr. Christodoulou. Dr. Grail, together with his affiliates, owns 15.4 million HEALWELL Shares and 15.4 million MVSs subject to the Call Right and Dr. Christodoulou, together with his affiliates, owns 15.4 million HEALWELL Shares and 15.4 million MVSs subject to the Call Right (together, the "Optioned Shares"). The Call Right is exercisable until October 1, 2026 and its exercise is conditional on the achievement by HEALWELL of a number of performance milestones designed to demonstrate improvements in HEALWELL's financial and capital markets performance, as well as obtaining any required Toronto Stock Exchange or regulatory approvals. The Call Right can only be exercised in pairs, such that WELL must concurrently acquire a HEALWELL Share and a MVS. Pursuant to the Call Option Agreement, on exercise of the Call Right, the price per security that will be paid for the Optioned Shares is
Additional information with respect to the Call Option Agreement and its material terms can be found in WELL's early warning report dated October 1, 2023, and in WELL's Notice of Meeting and Management Information Circular dated August 21, 2023 which is available on www.sedarplus.ca.
On December 16, 2024, HEALWELL and Orion Health Holdings Limited ("Orion Health") entered into a share purchase agreement, pursuant to which HEALWELL agreed to acquire
WELL intends to amend the terms of the Call Option Agreement to enable WELL to exercise the Call Right concurrent with the closing of the OHHL Acquisition (the "Closing").
As of the date hereof, WELL held beneficial ownership, directly or indirectly, or exercised control or direction over 65,923,161 HEALWELL Shares and 500,000 subscription receipts (each, a "Subscription Receipt"), each Subscription Receipt entitling WELL to receive, upon satisfaction of certain release conditions (namely, the closing of the OHHL Acquisition), and for no further consideration, one unit of HEALWELL, each unit consisting of one HEALWELL Share and one half of one share purchase warrant, with each whole share purchase warrant (each, a "Warrant") exercisable into one HEALWELL Share at the exercise price of
Immediately following the Closing, if the Call Right were to be fully exercised and all of the Optioned Shares were acquired by WELL, WELL would own, or exercise control or direction over 97,223,161 HEALWELL Shares, 30,800,000 MVSs and 250,000 Warrants.
It is anticipated that HEALWELL will have 261,547,371 HEALWELL Shares issued and outstanding on closing of the OHHL Acquisition, following the issuance of 35,643,478 HEALWELL Shares to the vendor, and 12,737,500 HEALWELL Shares in connection with the conversion of all 12,737,500 Subscription Receipts as part of the
WELL was approved as a control person of HEALWELL by resolutions of the shareholders of HEALWELL, on a disinterested basis, on September 21, 2023. The Toronto Stock Exchange subsequently approved WELL as a control person of HEALWELL on October 6, 2023.
WELL anticipates acquiring the HEALWELL Shares and MVSs concurrent with the closing of the OHHL Acquisition and will hold the HEALWELL Shares and MVSs for investment purposes. WELL intends to review its investment in HEALWELL on a continuing basis and may, from time to time and at any time subject to compliance with applicable securities laws, and depending on market and other conditions, acquire or dispose of equity, debt or other securities of HEALWELL through open market transactions, private placements and other privately negotiated transactions, or otherwise, in each case, depending on a number of factors, including general market and economic conditions and other factors and conditions WELL deems appropriate.
WELL is incorporated under the laws of the Province of
A copy of WELL's early warning report dated March 31, 2025 will be made available on sedarplus.ca under HEALWELL's profile.
____________________________________ |
View original content to download multimedia:https://www.prnewswire.com/news-releases/well-health-technologies-corp-early-warning-news-release-302416411.html
SOURCE WELL Health Technologies Corp.
FAQ
What is the value of WELL Health's (WHTCF) call option exercise for HEALWELL shares?
When will WELL Health (WHTCF) exercise its call option for HEALWELL shares?
What percentage of HEALWELL will WELL Health (WHTCF) own after exercising the call option?
How much is HEALWELL paying for the Orion Health acquisition?
